387 related articles for article (PubMed ID: 26077140)
1. Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥ 75 years after radical cystectomy for treatment of bladder cancer.
Hara T; Matsuyama H; Kamiryo Y; Hayashida S; Yamamoto N; Nasu T; Joko K; Baba Y; Suga A; Yamamoto M; Aoki A; Takai K; Yoshihiro S; Konishi M; Sakano S; Imoto K; Tei Y; Yamaguchi S; Yano S;
Int J Clin Oncol; 2016 Feb; 21(1):139-47. PubMed ID: 26077140
[TBL] [Abstract][Full Text] [Related]
2. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
3. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ
Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer.
Zhang J; Zhou X; Ding H; Wang L; Liu S; Liu Y; Chen Z
BMC Urol; 2020 Mar; 20(1):31. PubMed ID: 32192483
[TBL] [Abstract][Full Text] [Related]
5. Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.
Koie T; Ohyama C; Yamamoto H; Hatakeyama S; Imai A; Yoneyama T; Hashimoto Y; Kitayam M; Hirota K
Urol Oncol; 2014 Aug; 32(6):820-5. PubMed ID: 24951323
[TBL] [Abstract][Full Text] [Related]
6. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.
Bochner BH; Dalbagni G; Sjoberg DD; Silberstein J; Keren Paz GE; Donat SM; Coleman JA; Mathew S; Vickers A; Schnorr GC; Feuerstein MA; Rapkin B; Parra RO; Herr HW; Laudone VP
Eur Urol; 2015 Jun; 67(6):1042-1050. PubMed ID: 25496767
[TBL] [Abstract][Full Text] [Related]
7. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.
Hautmann RE; de Petriconi RC; Pfeiffer C; Volkmer BG
Eur Urol; 2012 May; 61(5):1039-47. PubMed ID: 22381169
[TBL] [Abstract][Full Text] [Related]
8. Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study.
Grimm T; Buchner A; Schneevoigt B; Kretschmer A; Apfelbeck M; Grabbert M; Jokisch JF; Stief CG; Karl A
World J Urol; 2016 May; 34(5):703-8. PubMed ID: 26376992
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of robot-assisted vs. open radical cystectomy.
Hanna N; Leow JJ; Sun M; Friedlander DF; Seisen T; Abdollah F; Lipsitz SR; Menon M; Kibel AS; Bellmunt J; Choueiri TK; Trinh QD
Urol Oncol; 2018 Mar; 36(3):88.e1-88.e9. PubMed ID: 29277584
[TBL] [Abstract][Full Text] [Related]
10. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
[TBL] [Abstract][Full Text] [Related]
11. Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience.
Moschini M; Karnes RJ; Sharma V; Gandaglia G; Fossati N; Dell'Oglio P; Cucchiara V; Capogrosso P; Shariat SF; Damiano R; Salonia A; Montorsi F; Briganti A; Gallina A; Colombo R
Eur J Surg Oncol; 2016 May; 42(5):735-43. PubMed ID: 26927300
[TBL] [Abstract][Full Text] [Related]
12. The surgical management of patients with clinical stage T4 bladder cancer: A single institution experience.
Moschini M; Luzzago S; Zaffuto E; Dell'Oglio P; Gandaglia G; Mattei A; Damiano R; Soria F; Klatte T; Shariat SF; Salonia A; Montorsi F; Briganti A; Gallina A; Colombo R
Eur J Surg Oncol; 2017 Apr; 43(4):808-814. PubMed ID: 27720312
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of pre-cystectomy hemoglobin levels in patients with invasive bladder cancer.
Schubert T; Todenhöfer T; Mischinger J; Schwentner C; Renninger M; Stenzl A; Gakis G
World J Urol; 2016 Jun; 34(6):829-34. PubMed ID: 26420594
[TBL] [Abstract][Full Text] [Related]
14. Does patient age affect survival after radical cystectomy?
Horovitz D; Turker P; Bostrom PJ; Mirtti T; Nurmi M; Kuk C; Kulkarni G; Fleshner NE; Finelli A; Jewett MA; Zlotta AR
BJU Int; 2012 Dec; 110(11 Pt B):E486-93. PubMed ID: 22551360
[TBL] [Abstract][Full Text] [Related]
15. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
[TBL] [Abstract][Full Text] [Related]
16. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
[TBL] [Abstract][Full Text] [Related]
17. Increased One-Year Mortality Among Elderly Patients After Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective, Observational Comparative Study.
Lemiński A; Kaczmarek K; Gołąb A; Kotfis K; Skonieczna-Żydecka K; Słojewski M
Clin Interv Aging; 2022; 17():255-263. PubMed ID: 35299721
[TBL] [Abstract][Full Text] [Related]
18. Lymphadenectomy for bladder cancer at the time of radical cystectomy.
Tilki D; Brausi M; Colombo R; Evans CP; Fradet Y; Fritsche HM; Lerner SP; Sagalowsky A; Shariat SF; Bochner BH
Eur Urol; 2013 Aug; 64(2):266-76. PubMed ID: 23648149
[TBL] [Abstract][Full Text] [Related]
19. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
20. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.
Koga F; Kihara K; Yoshida S; Yokoyama M; Saito K; Masuda H; Fujii Y; Kawakami S
BJU Int; 2012 Mar; 109(6):860-6. PubMed ID: 21854531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
